Doing battle with HCV

American Journal of Gastroenterology

Volumn 95, Issue 3, 2000, Pages 582-583

  Fimmel, Claus J ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; INTERFERON; RIBAVIRIN;

EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; GOVERNMENT; HEALTH CARE COST; HEALTH CARE SYSTEM; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SEROPREVALENCE; UNITED STATES;

EID: 0033993948     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)00704-8     Document Type: Editorial

References (8)

1. Department of Veterans Affairs Fact Sheet. VA: Hepatitis C Strategic Initiative. January, 1999.
2. Center for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998;47:RR-19, 1–39.
3. R.C. Cheung Epidemiology of hepatitis C virus infection in American veterans Am J Gastroenterol 95 2000 740 747
4. M. Briggs C. Baker E. Kim Prevalence of and risk factors for hepatitis C virus (HCV) infection in veterans utilizing routine phlebotomy at San Francisco Veterans’ Administration Hospital J Investig Med 47 1999 46A
5. D. Pham D. Walshe J. Montgomery Seroepidemiology of hepatitis C and B in an urban VA medical center Hepatology 25 1994 236A
6. McQuillan GM, Alter MJ, Moyer LA, et al. A population based serologic study of hepatitis C virus infection in the U.S. In: Rizzetto M, Purcell RH, Gerin JL, et al., eds. Viral hepatitis in liver disease. Turin: Edizioni Minerva Medica, 1997:267–70.
7. A.J. Muir D. Provenzale P.G. Killenberg An evaluation of eligibility for therapy among veterans with hepatitis C Hepatology 30 1999 A190
8. J.B. Wong G.M. McQuillan J.G. McHutchison Projecting future hepatitis C morbidity and mortality in the US An awakening giant? Hepatology 30 1999 505A